News & Analysis as of

Corporate Practice of Medicine

Rivkin Radler LLP

NYS Reinforces Its Scrutiny Over Healthcare Transactions

Rivkin Radler LLP on

We recently discussed increasing state regulation of healthcare mergers and acquisitions in the face of the current Administration’s clear policy of federal deregulation. We noted that 15 states had implemented oversight laws...more

Wilson Sonsini Goodrich & Rosati

The Corporate Practice of Medicine: Essential Guidance for Digital Health Companies and Investors

As digital health companies blossom from ideas into reality, navigating state regulations on the corporate practice of medicine (CPOM) is typically one of the first and most crucial legal hurdles to clear if the digital...more

Rivkin Radler LLP

State Laws Target Healthcare Investments as Feds Deregulate

Rivkin Radler LLP on

Will the new administration’s federal deregulation be a boon for private equity investment in healthcare providers, or will the states be the “new sheriff in town”? In the short time he has been in office, President Trump...more

Holland & Knight LLP

New York State Department of Health Issues Long-Awaited Guidance on Material Transactions Law

Holland & Knight LLP on

The New York State Department of Health (DOH) has published a set of Frequently Asked Questions (FAQs) to provide guidance on the "Disclosure of Material Transactions" law that took effect on Aug. 1, 2023. Pursuant to Article...more

Goodwin

States Continue to Pursue and Expand Healthcare Market Oversight at an Unprecedented Pace, with Significant Implications for...

Goodwin on

In recent years, states have shown an increased interest in regulating healthcare markets. The trend has accelerated further since the start of 2025, with a flurry of proposals in at least 12 states. ...more

McDermott Will & Emery

SB 5387 Aims to Codify Restrictive CPOM Doctrine in Washington

On January 21, 2025, the Washington state legislature introduced Senate Bill (SB) 5387, aiming to codify a restrictive state prohibition on the corporate practice of healthcare, commonly referred to as a corporate practice of...more

Goodwin

Health Headlines: February 2025

Goodwin on

Welcome to the third issue of Health Headlines, a newsletter created by lawyers in our Healthcare practice....more

Benesch

Healthcare Private Equity Investment: As Federal Headwinds Subside, a Gale Warning Goes Up in Many States

Benesch on

Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns...more

Fox Rothschild LLP

Florida’s Corporate Practice of Dentistry: Navigating Restrictions and the Role of Dental Practice Management Companies

Fox Rothschild LLP on

In Florida, the corporate practice of dentistry is subject to stringent regulations designed to ensure that only licensed dentists have control over dental practices. This regulatory framework is crucial for maintaining the...more

Polsinelli

California Reintroduces Legislation to Restrict Private Equity Management of Health Care Providers

Polsinelli on

The California legislature has introduced a bill that would implement some of the same restrictions on private equity health care investments as last year’s AB 3129....more

Holland & Knight LLP

New Year, Same Bill: California Reintroduces Bill Aimed at Healthcare Private Equity Investment

Holland & Knight LLP on

The California Senate on Feb. 12, 2025, introduced SB351 – a bill nearly identical to a portion of AB3129 from the previous legislative session. The bill, largely aimed at codifying corporate practice of medicine (CPOM) and...more

Holland & Knight LLP

Proposed Changes to New York's Material Transactions Law Expand Oversight

Holland & Knight LLP on

New York Gov. Kathy Hochul unveiled her executive budget proposal for State Fiscal Year (FY) 2025-2026 on Jan. 21, 2025, which includes amendments to the state's Disclosure of Material Transactions law. If the amendments are...more

Goodwin

Massachusetts Passes Comprehensive Revisions to Healthcare Transaction Notification Law with Significant Implications for Private...

Goodwin on

On January 8, 2025, Massachusetts Governor Maura Healey signed House Bill 5159 (H.5159), “An Act Enhancing the Market Review Process” (the “Act”), which, among other things, broadens the scope of the state’s existing...more

Latham & Watkins LLP

Healthcare and Life Science Deals Attorneys Expect In 2025

Latham & Watkins LLP on

As the healthcare industry heads into 2025, deals attorneys are optimistic as they look to falling interest rates and a potentially more business-friendly administration set to enter the White House. Originally published...more

Venable LLP

Event in Review: Healthcare Services Licensure and Change of Ownership Issues

Venable LLP on

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely...more

Whiteford

Understanding IRS Encouragement of PLRs for Healthcare Entities and Assessing Healthcare Corporate and Tax Structure For Tax...

Whiteford on

The IRS has recently been urging healthcare entities, particularly those involving physicians and private investors, to seek private letter rulings (PLRs) to clarify the tax implications of their ownership structures. This...more

Holland & Knight LLP

5 Key Takeaways from Panel Discussion with the California Office of Health Care Affordability

Holland & Knight LLP on

Holland & Knight hosted a virtual roundtable discussion on Nov. 4, 2024, with an esteemed panel featuring Sheila Tatayon, assistant deputy director of Health Systems Compliance and chief counsel for California's Office of...more

Holland & Knight LLP

5 Key Antitrust Takeaways from Holland & Knight's Panel at Nashville Healthcare Sessions 2024

Holland & Knight LLP on

2024 has been an eventful year for federal and state antitrust enforcement in healthcare with many in the industry wondering where do we go from here in 2025. Holland & Knight sponsored a breakout panel discussion at the...more

Fenwick & West LLP

Heart of Healthcare Podcast: FTC Chair Lina Khan on Healthcare, Antitrust, and the Future of Competition

Fenwick & West LLP on

In a recent episode of the Heart of Healthcare podcast, co-hosts Michael T. Esquivel and Halle Tecco, sat down with Federal Trade Commission (FTC) Chair Lina Khan, who offered her perspective on the intersection of antitrust...more

Holland & Knight LLP

California Governor Vetoes Assembly Bill 3129: What's Next?

Holland & Knight LLP on

California Gov. Gavin Newsom on Sept. 28, 2024, vetoed Assembly Bill (AB) 3129, a law that would have required private equity and hedge funds – and in some cases, their platform companies – to obtain the California Attorney...more

Goodwin

Governor Vetoes California Assembly Bill 3129, Regulating Private Equity- and Hedge Fund-backed Healthcare Transactions

Goodwin on

On Saturday, September 28, California Governor Gavin Newsom vetoed Assembly Bill 3129. ...more

Parker Poe Adams & Bernstein LLP

How Certificate of Need Reform Is Impacting Ambulatory Surgery Centers and What it Means for Your Business

Recent Certificate of Need (CON) reform will likely lead to increased activity in ambulatory surgery center (ASC) transactions and expansion. As we covered in a Parker Poe webinar this week, North Carolina, South Carolina,...more

Fenwick & West LLP

New Regulatory Challenges for Private Equity and Hedge Fund Healthcare Transactions: Understanding the Impact of California’s AB...

Fenwick & West LLP on

California’s healthcare ecosystem may soon experience significant regulatory changes as Assembly Bill 3129 (AB 3129) heads to Gov. Gavin Newsom's desk for approval....more

Husch Blackwell LLP

California Private Equity in Healthcare Legislation

Husch Blackwell LLP on

On August 31, the last day of its 2024 Legislative Session, the California Legislature approved Assembly Bill 3129 (Wood), which provides for notification to and review by the Attorney General of health care transactions...more

Goodwin

Antitrust & Competition Healthcare Quarterly Update Q2 2024

Goodwin on

In the second quarter, federal and state antitrust enforcers continued their intense scrutiny of consolidation in the healthcare market by implementing new initiatives and laws designed to gather additional information...more

146 Results
 / 
View per page
Page: of 6

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide